摘要
目的探讨穴位注射新斯的明治疗粘连性肠梗阻的方法及疗效。方法将90例粘连性肠梗阻患者随机分为3组,单纯保守治疗组30例,采用西医常规非手术疗法,包括如禁食、抗感染、补液、持续胃肠减压等;手术治疗组30例,入院后即行手术治疗;穴位注射新斯的明治疗组30例是常规治疗的同时给予应用新斯的明行穴位注射。结果穴位注射新斯的明治疗组治愈15例,总有效率为80.0%,复发率为16.7%;单纯保守治疗组治愈为12例,总有效率为80.0%,其复发率33.3%;手术治疗组治愈为19例,总有效率为93.3%,复发率为30.0%。穴位注射新斯的明治疗组较单纯保守治疗组及手术治疗组平均肛门排气时间提前10~48 h,排便时间提前15~36 h。肠蠕动恢复时间、肛门排气时间、排便时间较另两组明显缩短(P<0.01)。结论穴位注射新斯的明治疗粘连性肠梗阻,大大缩短了疗程,促使多数患者避免再次手术的痛苦,也能节省了住院的费用,是目前治疗粘连性肠梗阻的一种比较理想的治疗方法,临床值得推广应用。
Objective To investigate the clinical effect of neostigmine acupoints injection on adhesive intestinal obstruction.Methods Ninety cases of adhesive intestinal obstruction were randomly divided into conservative treatment group(n=30),surgery group(n=30) and neostigmine acupoints injection group(n=30).Patients in conservative treatment group received treatments including abrosia,anti-infection,fluid infusion and continuous gastrointestinal decompression,etc.Patients in surgery group received surgery after hospital admission.Patients in neostigmine group received neostigmine acupoints injection besides conventional treatment.Results In neostigmine group,15 cases were cured with 80.0% effective rate and 16.7% relapse rate;in conservative treatment group,12 cases were cured with 80.0% effective rate and 33.3% relapse rate;in surgery group,19 cases were cured with 93.3% effective rate and 30.0% relapse rate.Compared with conservative treatment group and surgery group,the mean anal exhaust time and defecation time in neostigmine group were 10~48 h and 15~36 h earlier,respectively Moreover,peristalsis recovery time,anal exhaust time,and defecation time were obviously shorter(P〈0.01).Conclusion The treatment of neostigmine acupoints injection for adhesive intestinal obstruction shorten the course of treatment.It is an ideal method for the treatment of adhesive intestinal obstruction and deserves to be applied to clinical practice. 更多
出处
《临床和实验医学杂志》
2012年第4期266-267,共2页
Journal of Clinical and Experimental Medicine
基金
广西钦州市科学技术局科技攻关课题(20101910)
关键词
粘连性肠梗阻
穴位注射
新斯的明
Adhesives intestinal obstruction; Point injection; Neostigmine;